tDCS + Cognitive Therapy for Stroke-related Cognitive Impairment
(TRAINS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a non-invasive brain stimulation method called transcranial direct current stimulation (tDCS), combined with cognitive therapy, can improve thinking skills in individuals who have recently experienced a stroke. Participants will receive either the actual tDCS treatment or a sham (fake) version while engaging in cognitive exercises. The goal is to determine if this combination can enhance the recovery of cognitive function, often affected after a stroke. This trial may suit those who had a stroke within the last four weeks and are experiencing memory or thinking problems. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research that could enhance stroke recovery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this technique is safe for stroke-related cognitive impairment?
Research has shown that transcranial direct current stimulation (tDCS) is generally safe for people. In a review of studies on stroke patients, only about 12% reported any side effects. The most common side effect was mild itching, occurring in 70% of those cases. Other effects, such as a burning sensation, were less common.
One study confirmed that tDCS is safe and useful for addressing cognitive problems after a stroke. As a non-invasive treatment, tDCS does not involve surgery or entering the body, making it a less risky option.
Overall, tDCS combined with cognitive therapy appears promising for improving brain function after a stroke, with few and mostly mild side effects.12345Why are researchers excited about this trial?
Researchers are excited about tDCS with cognitive therapy for stroke-related cognitive impairment because it offers a non-invasive approach that could enhance brain function. Unlike traditional therapies that primarily focus on rehabilitative exercises, tDCS uses a gentle electrical current to stimulate the brain, specifically targeting the dorsolateral prefrontal cortex. This method has the potential to accelerate cognitive improvements by directly influencing neural activity, making it a promising complement to existing therapies. Additionally, the combination of tDCS with cognitive therapy may provide a synergistic effect, enhancing the overall treatment outcome.
What evidence suggests that tDCS combined with cognitive therapy is effective for stroke-related cognitive impairment?
Research has shown that transcranial direct current stimulation (tDCS) can enhance thinking and memory in individuals struggling with these skills after a stroke. Studies have found that applying tDCS to specific brain areas can boost memory and other cognitive abilities. In this trial, participants will receive either active tDCS combined with cognitive therapy or a sham tDCS combined with cognitive therapy. Previous research has demonstrated that tDCS, when paired with cognitive therapy, significantly improves thinking skills and daily activities for stroke patients. As a non-invasive treatment, tDCS does not involve surgery or entering the body and is generally considered safe. These findings suggest that combining tDCS with cognitive therapy could be a promising approach to addressing cognitive problems after a stroke.23678
Who Is on the Research Team?
Kelly Sloane, MD
Principal Investigator
University of Pennsylvania
Roy Hamilton, PhD
Principal Investigator
University of Pennsylvania
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-90 who've had a stroke within the last 4 weeks and are now experiencing cognitive issues because of it. They must understand the study, follow simple commands, and not have serious neurological conditions (other than stroke), seizures, substance abuse problems, severe psychiatric disorders, unstable medical illnesses or metallic objects in their head.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 5 daily sessions of transcranial direct current stimulation (tDCS) paired with cognitive therapy
Follow-up
Participants are monitored for changes in cognitive performance after treatment
What Are the Treatments Tested in This Trial?
Interventions
- tDCS
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor